Antiplatelet therapy in cardiovascular disease: Current status and future directions
G Passacquale, P Sharma, D Perera… - British Journal of …, 2022 - Wiley Online Library
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
Antiplatelet therapy in cardiovascular disease: Current status and future directions
G Passacquale, P Sharma… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
Antiplatelet therapy in cardiovascular disease: Current status and future directions.
G Passacquale, P Sharma… - British Journal of …, 2022 - search.ebscohost.com
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
Antiplatelet therapy in cardiovascular disease: current status and future directions
G Passacquale, P Sharma, D Perera… - British Journal of Clinical …, 2022 - kclpure.kcl.ac.uk
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
Antiplatelet therapy in cardiovascular disease: Current status and future directions.
G Passacquale, P Sharma, D Perera… - British Journal of Clinical …, 2022 - europepmc.org
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
[HTML][HTML] Antiplatelet therapy in cardiovascular disease: Current status and future directions
G Passacquale, P Sharma, D Perera… - British Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …
and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk …